Fundraising FoxShouTi Inc.
NASDAQ: GPCRSouth San Francisco, US · Founded 2019 · Incorporated in Cayman Islands · 2 known investors
Find your way into ShouTi Inc.
Sign up to see every warm intro you have to ShouTi Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ShouTi Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ShouTi Inc. is a clinical-stage biopharmaceutical company developing oral small molecule drugs targeting G-protein coupled receptors to treat chronic diseases including obesity, type 2 diabetes, and cardiovascular conditions. The company's lead candidate, aleniglipron, is a GLP-1 receptor agonist in clinical development, supported by a platform combining structure-based drug discovery and computational chemistry.
Founders & leadership
ShouTi Inc. was founded in 2019 by Raymond Stevens.
Board
Investors · 2
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$165M disclosed across 4 of 6 rounds · 1900–2021
▶$7MraisedJan 2022 · 8 investors · BiotechnologyRule 506(b)
- Jun YoonDirector
- Raymond StevensDirector
- Ramy FaridDirector
- Ting XieDirector
- Robert WeisskoffDirector
- Daniel AuerbachDirector
- Chen Ming YuDirector
- Cuiping GuDirector
- Jessica LiftonDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Dec 2021
- Incorporated
- Other, Cayman Islands, 2019
- Federal exemptions
- 06b
▶$26MraisedOct 2021 · 9 investors · BiotechnologyRule 506(b)
- Jun YoonDirector
- Robert WeisskoffDirector
- Ramy FaridDirector
- Raymond StevensDirector
- Daniel AuerbachDirector
- Chen Ming YuDirector
- Cuiping GuDirector
- Jessica LiftonDirector
- Ting XieDirector
- Offering amount
- $26M
- Amount sold
- $26M
- First sale
- Mar 2020
- Incorporated
- Other, Cayman Islands, 2019
- Federal exemptions
- 06b
▶$32MraisedOct 2021 · 6 investors · BiotechnologyRule 506(b)
- Daniel AuerbachDirector
- Raymond StevensDirector
- Jessica LiftonDirector
- Jun YoonDirector
- Ting XieDirector
- Ramy FaridDirector
- Chen Ming YuDirector
- Cuiping GuDirector
- Robert WeisskoffDirector
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Apr 2019
- Incorporated
- Other, Cayman Islands, 2019
- Federal exemptions
- 06b
▶$100MraisedOct 2021 · 30 investors · BiotechnologyRule 506(b)
- Robert WeisskoffDirector
- Ramy FaridDirector
- Jessica LiftonDirector
- Ting XieDirector
- Raymond StevensDirector
- Daniel AuerbachDirector
- Cuiping GuDirector
- Jun YoonDirector
- Chen Ming YuDirector
- Offering amount
- $100M
- Amount sold
- $100M
- Sales commissions
- $3.1M
- Placement agents
- SVB Leerink LLC
- First sale
- Jul 2021
- Incorporated
- Other, Cayman Islands, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does ShouTi Inc. do?
- ShouTi Inc. is a clinical-stage biopharmaceutical company developing oral small molecule drugs targeting G-protein coupled receptors to treat chronic diseases including obesity, type 2 diabetes, and cardiovascular conditions. The company's lead candidate, aleniglipron, is a GLP-1 receptor agonist in clinical development, supported by a platform combining structure-based drug discovery and computational chemistry.
- Who founded ShouTi Inc.?
- ShouTi Inc. was founded by Raymond Stevens in 2019.
- Who are ShouTi Inc.'s investors?
- ShouTi Inc.'s investors include Biotechnology Value Fund, F-Prime Capital.
- How much funding has ShouTi Inc. raised?
- ShouTi Inc. has disclosed $165M raised across 4 of its 6 known rounds.
- Where is ShouTi Inc. headquartered?
- ShouTi Inc. is headquartered in South San Francisco, US.